Stablecoins on Ethereum reach US$166 billion and consolidate DeFi
- Ethereum Stablecoin Supply Reaches All-Time High
- USDT leads with $87,8 billion in circulation
- Ethereum strengthens its role as the core infrastructure of DeFi
The total supply of stablecoins on the Ethereum network reached a historic milestone of $166 billion last Saturday, surpassing the $149 billion recorded the previous month. This increase reinforces blockchain's role as the primary infrastructure for settlements and operations in the decentralized finance (DeFi) ecosystem.
Among issuers, Tether (USDT) remains the leader with $87,8 billion allocated to the network, while USD Coin (USDC) ranks second with approximately $48 billion. This dominance of dollarized stablecoins highlights Ethereum's growing relevance as an essential liquidity layer in the sector.
Vincent Liu, CIO of Kronos Research, highlighted the impact of this expansion.
“Ethereum's stablecoin supply reaching an all-time high marks a watershed moment, transforming it from a speculative asset to a backbone of dollarization in DeFi ecosystems.”
He stated. He further added that current liquidity demonstrates sufficient strength to absorb macroeconomic shocks and sustain market activity.
Nick Ruck, director of LVRG Research, reinforced Liu's view by pointing out that the record achieved:
“means a massive increase in institutional liquidity and deeper trust in its infrastructure as a foundational layer for DeFi.”
According to Ruck, the supply expansion was driven primarily by the growth of USDT and USDC, reflecting the accelerated inflow of institutional capital. This movement, he believes, could generate greater activity in decentralized protocols and even boost the appreciation of Ether (ETH), Ethereum's native asset, given the growing demand for liquidity.
In addition to the record high on the Ethereum network, USDT's market cap also showed strength. Over the weekend, the stablecoin's market cap surpassed the $170 billion mark, reaching $170,3 billion early Monday morning (Eastern Time).
The growth in the supply of stablecoins confirms Ethereum's role as the foundation of DeFi transactions, where stable and scalable liquidity is seen as a pillar to support the growth of new blockchain-based financial applications and interactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint
As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.
"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight
KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.
Crypto prices
More
